Your browser doesn't support javascript.
loading
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
Yang, Sheng; Wu, Shiman; Zhao, Yanqiu; Chen, Gongyan; Zhu, Bo; Li, Xingya; Wang, Ke; Shi, Jianhua; Cang, Shundong; Yao, Wenxiu; Fan, Yun; Fang, Jian; Zhang, Liangming; Zhou, Jianying; Wu, Lin; Zheng, Rongsheng; Huang, Meijuan; Pan, Yueyin; Yang, Zhixiong; Sun, Meili; Yu, Huiqing; Wang, Donglin; Huang, Jianan; Wang, Lijun; Shu, Yongqian; Chen, Zhaohong; Liu, Chunling; Li, Jingzhang; Liu, Jiwei; Sun, Shenghua; Guo, Yanzhen; Meng, Zili; Liu, Zhefeng; Han, Zhigang; Wu, Gang; Lu, Hong; Ma, Rui; Hu, Sheng; Zhao, Guofang; Zhang, Longzhen; Liu, Zheng; Xie, Congying; Zhong, Diansheng; Zhao, Hui; Bi, Minghong; Yi, Shanyong; Guo, Shuliang; Yi, Tienan; Li, Wen; Lin, Yingcheng.
Affiliation
  • Yang S; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing, People's Republic of
  • Wu S; Department of Respiratory Medicine, The First Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
  • Zhao Y; Department of Respiratory Medicine, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Chen G; Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China.
  • Zhu B; Department of Oncology, Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
  • Li X; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
  • Wang K; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China.
  • Shi J; Department of Medical Oncology, Linyi Cancer Hospital, Linyi, People's Republic of China.
  • Cang S; Department of Medical Oncology, Henan Provincial People's Hospital, Zhengzhou, People's Republic of China.
  • Yao W; Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, People's Republic of China.
  • Fan Y; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
  • Fang J; Department of Thoracic Oncology, Beijing Cancer Hospital, Beijing, People's Republic of China.
  • Zhang L; Department of Medical Oncology, Yantai Yuhuangding Hospital, Yantai, People's Republic of China.
  • Zhou J; Department of Respiratory Medicine, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, People's Republic of China.
  • Wu L; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, People's Republic of China.
  • Zheng R; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China.
  • Huang M; Thoracic Oncology Ward, Division of Medical Oncology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Pan Y; Department of Thoracic Cancer Chemotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, People's Republic of China.
  • Yang Z; Cancer Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, People's Republic of China.
  • Sun M; Department of Oncology, Jinan Central Hospital Shandong University, Jinan, People's Republic of China.
  • Yu H; Department of Palliative Care, Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China.
  • Wang D; Department of Palliative Care, Department of Geriatric Oncology, Chongqing University Cancer Hospital, Chongqing, People's Republic of China.
  • Huang J; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Wang L; Cancer Center, The Second Affiliated Hospital of Xingtai Medical College, Xingtai, People's Republic of China.
  • Shu Y; Department of Oncology, Jiangsu Province Hospital, Nanjing, People's Republic of China.
  • Chen Z; Department of Oncology, People's Hospital of Deyang City, Deyang, People's Republic of China.
  • Liu C; Pulmonary Cancer Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.
  • Li J; Department of Oncology, Liuzhou People's Hospital, Liuzhou, People's Republic of China.
  • Liu J; Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
  • Sun S; Department of Respiratory Medicine, Third Xiangya Hospital of Central South University, Changsha, People's Republic of China.
  • Guo Y; Department of Medical Oncology, The First Affiliated Hospital of Henan University of Science & Technology, Luoyang, People's Republic of China.
  • Meng Z; Department of Respiratory Medicine, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaian, People's Republic of China.
  • Liu Z; Department of Oncology, Chinese PLA General Hospital, Beijing, People's Republic of China.
  • Han Z; Pulmonary Cancer Medicine, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, People's Republic of China.
  • Wu G; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
  • Lu H; Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, People's Republic of China.
  • Ma R; Department of Thoracic Oncology, Liaoning Cancer Hospital & Institute, Shenyang, People's Republic of China.
  • Hu S; Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, People's Republic of China.
  • Zhao G; Department of Thoracic Surgery, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, People's Republic of China.
  • Zhang L; Department of Radiotherapy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, People's Republic of China.
  • Liu Z; Department of Oncology, HanDan Central Hospital, Handan, People's Republic of China.
  • Xie C; Department of Radiotherapy, The 1st Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China.
  • Zhong D; Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.
  • Zhao H; Department of Respiratory Medicine, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China.
  • Bi M; Department of Medical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People's Republic of China.
  • Yi S; Department of Medical Oncology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, People's Republic of China.
  • Guo S; Department of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Yi T; Department of Oncology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences, Xiangyang, People's Republic of China.
  • Li W; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital Zhejiang University School of Medicine. Hangzhou, People's Republic of China.
  • Lin Y; Department of Medical Oncology, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Lung Cancer ; 180: 107194, 2023 06.
Article in En | MEDLINE | ID: mdl-37163774

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Type of study: Systematic_reviews Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antineoplastic Agents Type of study: Systematic_reviews Limits: Humans Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article